Aurinia Pharmaceuticals Inc · NASDAQ:AUPH
Hearne Michael S received 116,144 Aurinia Pharmaceuticals Inc shares as an award (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Hearne Michael S (Chief Financial Officer) received 116,144 Aurinia Pharmaceuticals Inc shares as an award, leaving 116,144 shares. Filed May 20, 2026 (Form 4).
- Awarded
- 116,144 shares
- Holding after
- 116,144 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Award | 116,144 | 116,144 | Direct |
Source
Related
- Aurinia Pharmaceuticals Inc
- Hearne Michael S
- Aurinia Pharmaceuticals Inc shareholders
- Form 4 · Robertson Stephen P. · Sep 11, 2026
- Schedule 13D/A · ILJIN SNT Co., Ltd. · Aug 26, 2026
- Form 4 · Robertson Stephen P. · Aug 25, 2026
- Schedule 13D/A · Tang Capital Management LLC · Jun 4, 2026
- Form 4 · Tang Kevin · Jun 2, 2026